»
Antikörper
»
anti-3'(2'), 5'-Bisphosphate Nucleotidase 1 (BPNT1) Antikörper
3'(2'), 5'-Bisphosphate Nucleotidase 1 (BPNT1) Antikörper
| Antigen |
|
| Synonyme |
PIP, BPntase, Sal3, MGC93112, MGC82412, BPNT1, MGC126947 |
| Klonalität |
Polyklonal |
|
Wirt
|
|
|
Applikation
|
|
| Produktnummer |
ABIN631707 |
| Menge |
50 ug (1 mg/ml) |
| Preis |
432,69 € Zzgl. Versandkosten €20,00 und MWSt
|
| Lieferung nach |
|
| Verfügbarkeit |
Lieferung in 5 bis 7 Werktagen |
|
Weitere Bezeichnung
|
BPNT1
|
|
Immunogen
|
BPNT1 antibody was raised using a synthetic peptide corresponding to a region with amino acids DRVTIQELTAPLLTTAQAKPGETQEEETNSGEEPFIETPRQDGVSRRFIP
|
|
Beschreibung
|
BPNT1, also called bisphosphate 3-prime-nucleotidase, or BPntase, is a member of a magnesium-dependent phosphomonoesterase family. Lithium, a major drug used to treat manic depression, acts as an uncompetitive inhibitor of BPntase. The predicted human protein is 92% identical to mouse BPntase. BPntase's physiologic role in nucleotide metabolism may be regulated by inositol signaling pathways. The inhibition of human BPntase may account for lithium-induced nephrotoxicity.
|
|
Molekulargewicht
|
29 kDa (MW of target protein)
|
|
Konzentration
|
1 mg/ml
|
|
Reinigung
|
Affinity purified
|
|
Buffer
|
Lyophilized powder. Add 50ul distilled water for a 1mg/ml concentration of BPNT1 antibody in PBS
|
|
Lagerung
|
Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
|
|
Forschungsgebiet
|
Neurologie, DNS/RNS
|
|
Beschränkungen
|
Nur für Forschungszwecke einsetzbar
|
Alternativen zu Antigen "3'(2'), 5'-Bisphosphate Nucleotidase 1 (BPNT1)", Typ "Antikörper" finden
|
Wirte
|
Maus (6), Ziege (5), Kaninchen (5)
|
|
Reaktivitäten
|
Human (15), Rind (Kuh) (1), Hund (1), Maus (1), Ratte (Rattus) (1)
|
|
Applikationen
|
Western Blot (WB) (14), Enzyme Immunoassay (EIA) (6), ELISA (4), Immunfluoreszenz (IF) (3), Immunhistochemie (Paraffinschnitte) (IHC (p)) (3), ELISA (Detektionsantikörper) (1)
|
|
Epitope
|
C-Term (1)
|